XTalks

APRIL 7, 2021

As the COVID-19 pandemic shifts with new case surges largely owing to new variants of SARS-CoV-2, the US Food and Drug Administration (FDA) continues to offer up emergency use authorizations (EUA) for tests for the detection of COVID-19 infection, with the latest being antibody and antigen tests from Symbiotic and Quidel, respectively.

Antibody 102

Antibody Immune Response Radiology Marketing 102

XTalks

MARCH 10, 2021

Adding to the testing repertoire is the first T cell-based test that can detect previous infection, akin to antibody tests. The persistence of antibodies after both natural COVID-19 infection and vaccination continues to be an area of intense study. 1. First T-Cell Test from Adaptive Biotechnologies.

Protein 98

Protein RNA Antibody Production 98

XTalks

JULY 10, 2024

Additionally, the test delivers results in about an hour and accurately detects active HCV infection from individuals at risk, or those with signs and symptoms of HCV infection, regardless of the presence of HCV antibodies. “This is the first HCV RNA detection technology sensitive enough for active case finding at the point of care.

RNA 97

RNA In-Vitro Genotype Marketing 97

pharmaphorum

MARCH 11, 2021

Estimates of medical diagnostics worth to the UK vary – MedTech Europe puts its value at around £1billion while the Office for Life Sciences reported in 2018 that it accounts for around 27% of the £24 billion turnover generated annually by the UK’s medtech sector.

In-Vitro 71

In-Vitro Containment Radiology Life Science 71

XTalks

AUGUST 30, 2022

Such therapies may involve small interfering RNA (siRNA) or oligonucleotides in viral transfection platforms, large molecules and antibodies. What About Small Proteins and Antibodies Reaching Extracellular CNS Targets? Vornov, nusinersen is driving much of what is being currently seen in drug development.

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

JANUARY 19, 2024

To specifically target cancer cells, alpha-emitting radionuclides are often attached to molecules that have a high affinity for cancer cells, such as antibodies or peptides (ligands). Due to their short range, alpha particles can destroy cancer cells while minimizing damage to surrounding healthy tissue.

DNA 66

DNA Radiology FDA Approval Development 66

XTalks

NOVEMBER 7, 2022

Another method to isolate CTCs is by antibody targeting of white blood cells for removal, followed by collection of untagged CTCs. Bahassi, while stating that several studies have shown there sometimes could be 30 to 300 times more CTCs in circulation than what CellSearch was able to detect. percent show less reliability).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98